Balance sheet components (Tables)

3 Months Ended

Mar. 31, 2026

Balance sheet components

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31, 2026		December 31, 2025
Clinical development expenses	$	9,363	$	7,036
Manufacturing expenses		5,286		9,462
Compensation and related benefits		3,068		11,527
Development milestones		986		10,000
Other		3,175		3,626
Total accrued expenses and other current liabilities	$	21,878	$	41,651